Safety and Efficacy of Gadobutrol 1.0 Molar ( Gadavist ) in Patients for Central Nervous System (CNS) Imaging

Clinical trial NCT00623467 · COMPLETED

Trial details

NCT number: NCT00623467
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Central Nervous System Diseases

Start date: 2007-12-01
Primary completion: 2008-12-01
Enrollment: 343

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.